Construction of a dominant negative form of human hypoxia-inducible factor-2α

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 10, 2010, Pages 2100-2102

  Higashimura, Yasuki ^a   Yamaji, Ryoichi ^a   Harada, Naoki ^a   Nakao, Motoyuki ^a   Nakano, Yoshihisa ^b   Inui, Hiroshi ^a  

^a Osaka Prefecture University   (Japan)

^b Osaka Women's Junior College   (Japan)

Author keywords

Dominant negative form; Hypoxia; Hypoxia inducible factor 1 ; Hypoxia inducible factor 1 ; Hypoxia inducible factor 2

Indexed keywords

DOMINANT NEGATIVE; HYPOXIA; HYPOXIA RESPONSE ELEMENTS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTORS; THERAPEUTIC TOOLS; TRANSCRIPTIONAL ACTIVITY;

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; ISOPROTEIN; MESSENGER RNA;

ARTICLE; CELL STRAIN HEK293; DNA RESPONSIVE ELEMENT; DOMINANT GENE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; GENES, DOMINANT; HEK293 CELLS; HUMANS; PROTEIN ENGINEERING; PROTEIN ISOFORMS; RESPONSE ELEMENTS; RNA, MESSENGER;

EID: 78049390983     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.100208     Document Type: Article

References (18)

1. Coleman ML and Ratcliffe PJ, Essays Biochem., 43, 1-15 (2007).
2. Gordan JD and Simon MC, Curr. Opin. Genet. Dev., 17, 71-77 (2007).
3. Wang GL, Jiang BH, Rue EA, and Semenza GL, Proc. Natl. Acad. Sci. USA, 92, 5510-5514 (1995).
4. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, and Fujii-Kuriyama Y, Proc. Natl. Acad. Sci. USA, 94, 4273-4278 (1997).
5. Lee JW, Bae SH, Jeong JW, Kim SH, and Kim KW, Exp. Mol. Med., 36, 1-12 (2004).
6. Wang V, Davis DA, Haque M, Huang LE, and Yarchoan R, Cancer Res., 65, 3299-3306 (2005).
7. Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, and Simon MC, Mol. Cell. Biol., 26, 3514-3526 (2006).
8. Hu CJ, Sataur A, Wang L, Chen H, and Simon MC, Mol. Biol. Cell, 18, 4528-4542 (2007).
9. Semenza GL, Nat. Rev. Cancer, 3, 721-732 (2003).
10. Kietzmann T, Cornesse Y, Brechtel K, Modaressi S, and Jungermann K, Biochem. J., 354, 531-537 (2001).
11. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, Wiesener M, and Eckardt KU, FASEB J., 18, 1462-1464 (2004).
12. Yan Q, Bartz S, Mao M, Li L, and Kaelin WGJr, Mol. Cell. Biol., 27, 2092-2102 (2007).
13. Hu CJ, Wang LY, Chodosh LA, Keith B, and Simon MC, Mol. Cell. Biol., 23, 9361-9374 (2003).
14. Won J, Chang S, Oh S, and Kim TK, Proc. Natl. Acad. Sci. USA, 101, 11328-11333 (2004).
15. Chun YS, Choi E, Yeo EJ, Lee JH, Kim MS, and Park JW, J. Cell Sci., 114, 4051-4061 (2001).
16. Chun YS, Choi E, Kim TY, Kim MS, and Park JW, Biochem. J., 362, 71-79 (2002)
17. Kung AL, Wang S, Klco JM, Kaelin WG, and Livingston DM, Nat. Med., 6, 1335-1340 (2000).
18. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, and Simons JW, Cancer Res., 59, 5830-5835 (1999).